![Profile Image](https://pbs.twimg.com/profile_images/1138172373390307329/vfzeyP7D_normal.png)
Rep. Katie Porter @RepKatiePorter
The cost of a three month supply of Revlimid, a cancer drug, increased by ~$3,600 in January 2022—even though this Big Pharma CEO couldn't justify price hikes on the medicine when I asked about it in 2020. This week, my colleagues and I wrote to @PhRMA demanding an explanation. — PolitiTweet.org
Rep. Katie Porter @RepKatiePorter
Half a million dollars. That's the bonus a Big Pharma CEO got for hiking the price of ONE cancer treatment drug.… https://t.co/Od6s0ZHA3y